|
Volumn 12, Issue 2, 2006, Pages 175-177
|
Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTISENSE OLIGONUCLEOTIDE;
DYSTROPHIN;
MORPHOLINE DERIVATIVE;
MORPHOLINO PHOSPHORODIAMIDATE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CONTROLLED STUDY;
DUCHENNE MUSCULAR DYSTROPHY;
EXON;
FUNCTIONAL PROTEOMICS;
GENE FUNCTION;
GENE MUTATION;
GENETIC TRANSCRIPTION;
MOUSE;
MOUSE STRAIN;
MUSCLE FUNCTION;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
SKELETAL MUSCLE;
TREATMENT OUTCOME;
ANIMALS;
BASE SEQUENCE;
DRUG ADMINISTRATION SCHEDULE;
DYSTROPHIN;
GENE EXPRESSION REGULATION;
GENE THERAPY;
HUMANS;
INJECTIONS, INTRAVENOUS;
MALE;
MICE;
MICE, INBRED C57BL;
MICE, INBRED MDX;
MUSCLE, SKELETAL;
MUSCULAR DYSTROPHY, ANIMAL;
MUSCULAR DYSTROPHY, DUCHENNE;
OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE;
ANIMALIA;
|
EID: 32244443828
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm1345 Document Type: Article |
Times cited : (446)
|
References (15)
|